4198 Stock Overview
Focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
S&S Healthcare Holding Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$32.35 |
52 Week High | NT$61.90 |
52 Week Low | NT$22.10 |
Beta | 0.24 |
11 Month Change | -15.76% |
3 Month Change | -15.31% |
1 Year Change | 29.40% |
33 Year Change | -4.85% |
5 Year Change | 42.20% |
Change since IPO | -96.88% |
Recent News & Updates
Shareholder Returns
4198 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | -2.1% | 0.9% | 1.8% |
1Y | 29.4% | 18.4% | 34.2% |
Return vs Industry: 4198 exceeded the TW Medical Equipment industry which returned 18.4% over the past year.
Return vs Market: 4198 underperformed the TW Market which returned 34.2% over the past year.
Price Volatility
4198 volatility | |
---|---|
4198 Average Weekly Movement | 7.4% |
Medical Equipment Industry Average Movement | 4.9% |
Market Average Movement | 5.7% |
10% most volatile stocks in TW Market | 9.4% |
10% least volatile stocks in TW Market | 3.1% |
Stable Share Price: 4198's share price has been volatile over the past 3 months.
Volatility Over Time: 4198's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | n/a | n/a | www.swissray.com |
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd.
S&S Healthcare Holding Ltd. Fundamentals Summary
4198 fundamental statistics | |
---|---|
Market cap | NT$779.89m |
Earnings (TTM) | NT$109.99m |
Revenue (TTM) | NT$331.19m |
7.1x
P/E Ratio2.4x
P/S RatioIs 4198 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4198 income statement (TTM) | |
---|---|
Revenue | NT$331.19m |
Cost of Revenue | NT$269.20m |
Gross Profit | NT$61.99m |
Other Expenses | -NT$48.00m |
Earnings | NT$109.99m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.56 |
Gross Margin | 18.72% |
Net Profit Margin | 33.21% |
Debt/Equity Ratio | 21.8% |
How did 4198 perform over the long term?
See historical performance and comparison